Blood concentrate may boost healing of jaw bone damage from common drugs
NCT ID NCT07464678
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 22 people with jaw bone damage caused by medications for osteoporosis or cancer. They all had surgery to remove the damaged bone. Half also received a gel made from their own blood (platelet-rich fibrin) placed into the wound. The goal was to see if this gel helps the jaw heal better and reduces complications. Results will compare healing and quality of life over 6 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDICATION-RELATED OSTEONECROSIS OF THE JAW are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Uniwersytecki Szpital Kliniczny w Poznaniu
Poznan, Wielkopolska, 60-355 Poznań, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood-Derived clots could protect jaw bone after tooth removal
- New study uses 3D scans to track jaw bone damage from common osteoporosis drugs
- Could a common muscle drug and vitamin e heal jaw bone death?
- Dental implant dilemma: to keep or remove when jaw bone dies?
- Can MRI predict radiation side effects before they happen?
- New surgical technique aims to heal jaw bone damage from medications